Eaton Financial Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$914K Buy
15,864
+4,140
+35% +$238K 0.25% 67
2026
Q1
$711K Buy
11,724
+492
+4% +$28.7K 0.23% 79
2025
Q4
$606K Buy
11,232
+1,903
+20% +$91.5K 0.16% 91
2025
Q3
$421K Buy
9,329
+2,758
+42% +$129K 0.12% 102
2025
Q2
$304K Buy
+6,571
New +$323K 0.09% 101
2023
Q4
Sell
-5,476
Closed -$318K 157
2023
Q3
$318K Buy
5,476
+950
+21% +$58.2K 0.09% 144
2023
Q2
$289K Sell
4,526
-675
-13% -$45.3K 0.22% 47
2023
Q1
$360K Sell
5,201
-190
-4% -$13.4K 0.28% 41
2022
Q4
$388K Buy
+5,391
New +$406K 0.33% 46

Other funds holding BMY

Eaton Financial Holdings's BMY Position: Q2 2026 in Review

Eaton Financial Holdings increased its Bristol-Myers Squibb (BMY) stake by 35% in Q2 2026, buying an estimated $238K and bringing the position to 15,864 shares worth $914K. The position accounts for 0.25% of the portfolio, ranked #67.

Eaton Financial Holdings first reported a position in BMY in Q4 2022 and has held it in 9 quarters since. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Eaton Financial Holdings held 15,864 shares of Bristol-Myers Squibb worth $914K as of Q2 2026.
  • Eaton Financial Holdings bought 4,140 Bristol-Myers Squibb shares in Q2 2026, an estimated $238K.
  • Bristol-Myers Squibb made up 0.25% of Eaton Financial Holdings's portfolio in Q2 2026, its #67 holding.
  • Eaton Financial Holdings first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 9 quarters since.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Eaton Financial Holdings's 13F filing for Q2 2026, filed 5 Aug 2026.